Medications and vocational rehabilitation are both integral to the recovery process for schizophrenia. The development of new medications for schizophrenia, combined with promising research on supported employment, has led to renewed attention to the interrelationship between the two. These new medications have fewer motor side effects and greater impact on cognitive functioning than traditional medications. Consequently, they are hypothesized to enable more consumers to benefit from rehabilitation programs and to obtain competitive jobs. More rigorous research is needed in all of these areas. Suggestions are offered to rehabilitation professionals regarding the role of medications in employment.
|Original language||English (US)|
|Number of pages||8|
|Journal||Journal of Rehabilitation|
|State||Published - Oct 1 1999|